Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2025-06-30 00:00:00 ET · period of report 2025-06-26 · accession 0001610717-25-000270 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-30 | 2025-06-26 | RVMD | Borisy Alexis | Dir | A - Grant | $0.00 | +3,142 | 2.34M | +0.1% | $0 |
| D | 2025-06-30 | 2025-06-26 | RVMD | Borisy Alexis | Dir | A - Grant | $0.00 | +11.6K | 11.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-26 | A | A | 3,142 | $0.00 | 2,338,884 | D | — | — | (F1) Includes 3,142 Restricted Stock Units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-06-26 | A | A | 11,574 | $0.00 | 11,574 | D | $37.48 · — to 2035-06-26 | 11,574 Common Stock | (F2) Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date. |